Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
CHRNA5 |
cholinergic receptor, nicotinic alpha 5 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
2(1/1/0)
|
IBA
|
CHRNA4 |
cholinergic receptor, nicotinic alpha 4 |
20q13.33 |
Literature-origin |
1(1/0/0)
|
IBA; ISS
|
CHRNA2 |
cholinergic receptor, nicotinic alpha 2 |
8p21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IBA
|
CHRNA6 |
cholinergic receptor, nicotinic alpha 6 |
8p22 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
IBA
|
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IBA
|
CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
TAS[1330682]
|
CHRNA3 |
cholinergic receptor, nicotinic alpha 3 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
IBA; ISS
|
CHRNB3 |
cholinergic receptor, nicotinic beta 3 |
8p11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
TAS[7690916]
|
APOE |
apolipoprotein E |
19q13.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(2/4/0)
|
TAS[9622609]
|